Clinical Trial Update: Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating capecitabine in combination with SIR-Spheres in patients with metastatic liver cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• SIR-Spheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Metastatic Liver Cancer | Phase 1 | Status: COMPLETED